The MRCT Center has worked with stakeholders to develop case studies that illustrate (1) efforts for diversity, equity, and inclusion that have been successfully integrated into the clinical research enterprise, and (2) examples of therapeutic response differences that warrant investigation.
There are two types of case studies offered on this page: programmatic and therapeutic.
The programmatic case studies illustrate different organizational approaches to improve diversity in clinical trials, promote equity within their workplaces, build relationships with communities, and more.
The therapeutic case studies offer examples of differential treatment responses based on race, ethnicity, ancestry, and/or genetic variability.
The case highlights offer a case overview focusing on key takeaways while the full case studies provide further detail, explanation, and examples.
Programmatic Case Studies
Achieving and Exceeding Clinical Trial Participant Diversity Targets
How Merck increased clinical trial diversity using Customized Tools, Applications, and a Dynamic Enrollment Tracker
All of Us Research Program
How a large, unprecedented national study ensured over 80% enrollment of historically underrepresented participants
Data-driven Diversity Assessments at a Medical Device Company
How Boston Scientific utilizes data to systematically prioritize racial and ethnic diversity in cardiovascular treatment and clinical trials
Multiple Sclerosis Research Mythbusting Series
How Accelerated Cure Project (ACP) and the Multiple Sclerosis Association of America (MSAA) collaborated to further diverse clinical trial participation